Cargando…
Immunogenicity of SARS-CoV: the Receptor-Binding Domain of S Protein is a Major Target of Neutralizing Antibodies
Autor principal: | He, Yuxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124001/ https://www.ncbi.nlm.nih.gov/pubmed/17037594 http://dx.doi.org/10.1007/978-0-387-33012-9_98 |
Ejemplares similares
-
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
por: Yuan, Meng, et al.
Publicado: (2021) -
Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
por: Du, Lanying, et al.
Publicado: (2009) -
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
por: Chi, Xiaojing, et al.
Publicado: (2020) -
Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen
por: Srivastava, Vikram, et al.
Publicado: (2021) -
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
por: He, Yuxian, et al.
Publicado: (2004)